Alireza Moradi
Alireza Moradi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Mehran Baghi
Department of Otolaryngology, SINA Clinic, Obertshausen, Germany
3 shared publications - Ashkan Sherafat Vaziri
Department of Otolaryngology, SINA Clinic, Obertshausen, Germany
2 shared publications - Seied-Reza Seied-Mohammad Doulabi
Department of Otolaryngology, SINA Clinic, Obertshausen, Germany
2 shared publications Fahime Shamsian
Student of Medicine, Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication- Hadi Parhoon
Department of Psychology, Faculty of Social Sciences, Razi University
1 shared publication - Kamal Parhoon
Postdoc Researcher in Cognitive Psychology, Kharazmi University, Tehran, Iran
1 shared publication
Latest Publications
- 31 October 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
Risk thresholds for selective neck management in cN0 lower lip SCC: a decision-analytic prediction model
Management of the clinically node-negative (cN0) neck in lower lip squamous cell carcinoma (LLSCC) remains controversial because the risk of occult metastasis must be balanced against the morbidity of elective neck dissection (END). We aimed to identify predictors of early cervical nodal failure under an observation-first strategy and to translate them into a threshold-based decision-support framework. In this multicenter retrospective cohort, 208 consecutive LLSCC patients were screened, and 74 cN0 patients treated with primary tumor resection without upfront END were included. The primary endpoint was early cervical nodal failure within 12 months, defined as failure of surveillance. A full postoperative multivariable model including DOI, tumor size, and closest histopathologic margin was fitted for individualized postoperative risk estimation. A simplified DOI-size risk stratification scheme was constructed for clinically intuitive group-level interpretation and threshold-based decision support. Discrimination, calibration with bootstrap validation and shrinkage, ROC-derived thresholds, and decision curve analysis were performed. The simplified DOI-size strata were interpreted against a prespecified 20% elective-treatment threshold, with sensitivity analyses at 15% and 25%. Early nodal failure occurred in 15 of 74 patients (20.3%). DOI (OR 1.95 per mm, 95% CI 1.19 to 3.21, P = .008) and tumor size (OR 3.06 per cm, 95% CI 1.30 to 7.18, P = .010) independently predicted failure, whereas closest histopathologic margin showed an inverse but non-significant association (OR 0.74 per mm, 95% CI 0.52 to 1.06, P = .102). The full DOI-size-margin model achieved an apparent AUC of 0.85 with acceptable calibration after optimism correction, with a shrinkage slope of 0.86 and calibration-in-the-large of 0.03. ROC-derived thresholds were DOI ≥ 7 mm and tumor size ≥ 3 cm, while DOI ≥ 6 mm was retained as a conservative clinical boundary for simplified bedside stratification. The simplified DOI-size stratification separated 12-month nodal failure risk into 0.0% in the low-risk group (0/12), 12.2% in the intermediate-risk group (5/41), and 47.6% in the high-risk group (10/21). Only the high-risk group exceeded the prespecified 20% decision boundary. Decision curve analysis demonstrated superior net benefit of the full postoperative model compared with the reduced DOI-size model and treat-all or treat-none strategies across clinically relevant thresholds. In cN0 LLSCC managed without upfront END, a full postoperative prediction model incorporating DOI, tumor size, and closest histopathologic margin provides individualized estimation of early surveillance failure risk. DOI and tumor size remain the dominant clinically interpretable variables for simplified bedside risk stratification, while closest histopathologic margin contributes postoperative risk refinement in the full model. When embedded within a threshold-based framework, this combined approach supports selective rather than routine elective neck management. External validation is warranted.
- 31 October 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
Risk thresholds for selective neck management in cN0 lower lip SCC: a decision-analytic prediction model
Management of the clinically node-negative (cN0) neck in lower lip squamous cell carcinoma (LLSCC) remains controversial because the risk of occult metastasis must be balanced against the morbidity of elective neck dissection (END). We aimed to identify predictors of early cervical nodal failure under an observation-first strategy and to translate them into a threshold-based decision-support framework. In this multicenter retrospective cohort, 208 consecutive LLSCC patients were screened, and 74 cN0 patients treated with primary tumor resection without upfront END were included. The primary endpoint was early cervical nodal failure within 12 months, defined as failure of surveillance. A full postoperative multivariable model including DOI, tumor size, and closest histopathologic margin was fitted for individualized postoperative risk estimation. A simplified DOI-size risk stratification scheme was constructed for clinically intuitive group-level interpretation and threshold-based decision support. Discrimination, calibration with bootstrap validation and shrinkage, ROC-derived thresholds, and decision curve analysis were performed. The simplified DOI-size strata were interpreted against a prespecified 20% elective-treatment threshold, with sensitivity analyses at 15% and 25%. Early nodal failure occurred in 15 of 74 patients (20.3%). DOI (OR 1.95 per mm, 95% CI 1.19 to 3.21, P = .008) and tumor size (OR 3.06 per cm, 95% CI 1.30 to 7.18, P = .010) independently predicted failure, whereas closest histopathologic margin showed an inverse but non-significant association (OR 0.74 per mm, 95% CI 0.52 to 1.06, P = .102). The full DOI-size-margin model achieved an apparent AUC of 0.85 with acceptable calibration after optimism correction, with a shrinkage slope of 0.86 and calibration-in-the-large of 0.03. ROC-derived thresholds were DOI ≥ 7 mm and tumor size ≥ 3 cm, while DOI ≥ 6 mm was retained as a conservative clinical boundary for simplified bedside stratification. The simplified DOI-size stratification separated 12-month nodal failure risk into 0.0% in the low-risk group (0/12), 12.2% in the intermediate-risk group (5/41), and 47.6% in the high-risk group (10/21). Only the high-risk group exceeded the prespecified 20% decision boundary. Decision curve analysis demonstrated superior net benefit of the full postoperative model compared with the reduced DOI-size model and treat-all or treat-none strategies across clinically relevant thresholds. In cN0 LLSCC managed without upfront END, a full postoperative prediction model incorporating DOI, tumor size, and closest histopathologic margin provides individualized estimation of early surveillance failure risk. DOI and tumor size remain the dominant clinically interpretable variables for simplified bedside risk stratification, while closest histopathologic margin contributes postoperative risk refinement in the full model. When embedded within a threshold-based framework, this combined approach supports selective rather than routine elective neck management. External validation is warranted.
- 6 January 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (5) , 2815-2826
Stem cell–based and gene editing strategies in the treatment of congenital and acquired sensorineural hearing loss: a narrative review
Background Sensorineural hearing loss (SNHL) represents the most common sensory deficit in humans and is increasingly prevalent with aging. Despite diverse etiologies, irreversible degeneration of cochlear hair cells and neurons remains a final pathway for auditory decline. Objective This narrative review synthesizes current preclinical and early clinical evidence on gene- and stem cell–based strategies for congenital and acquired SNHL, highlighting translational progress, delivery innovations, and persisting limitations. Methods A structured literature and registry search (PubMed, Embase, Scopus, Web of Science, ClinicalTrials.gov, EudraCT) was conducted using Boolean combinations of disease-, gene-, vector-, and delivery-related terms. From 140 initial records, 46 eligible studies were included after full-text screening. Data were qualitatively analyzed across two streams—human clinical (gene therapy) and preclinical/experimental (gene editing, RNA-based modulation, stem-cell regeneration). Results Two independent first-in-human AAV-mediated OTOF replacement trials in children with DFNB9 demonstrated partial restoration of hearing, establishing the first clinical proof-of-concept for cochlear gene therapy. Preclinical studies confirm durable auditory and vestibular rescue using dual-AAV systems, while CRISPR-based editing, antisense oligonucleotides (ASOs), and RNA interference (RNAi) approaches show mechanistic feasibility. Induced pluripotent stem cells (iPSCs) and inner-ear organoids replicate key developmental pathways, supporting modeling and future cellular repair. Delivery precision via the round window, oval window, and microneedle systems remains the major translational bottleneck. Conclusions Gene- and cell-based approaches are transforming auditory regenerative medicine. Among them, AAV-mediated OTOF replacement has reached clinical validation, whereas CRISPR, ASO/RNAi, and iPSC-derived regeneration continue at advanced preclinical stages. Future success will depend on refining delivery, ensuring long-term safety, and harmonizing ethical and regulatory oversight.
- 6 January 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (5) , 2815-2826
Stem cell–based and gene editing strategies in the treatment of congenital and acquired sensorineural hearing loss: a narrative review
Background Sensorineural hearing loss (SNHL) represents the most common sensory deficit in humans and is increasingly prevalent with aging. Despite diverse etiologies, irreversible degeneration of cochlear hair cells and neurons remains a final pathway for auditory decline. Objective This narrative review synthesizes current preclinical and early clinical evidence on gene- and stem cell–based strategies for congenital and acquired SNHL, highlighting translational progress, delivery innovations, and persisting limitations. Methods A structured literature and registry search (PubMed, Embase, Scopus, Web of Science, ClinicalTrials.gov, EudraCT) was conducted using Boolean combinations of disease-, gene-, vector-, and delivery-related terms. From 140 initial records, 46 eligible studies were included after full-text screening. Data were qualitatively analyzed across two streams—human clinical (gene therapy) and preclinical/experimental (gene editing, RNA-based modulation, stem-cell regeneration). Results Two independent first-in-human AAV-mediated OTOF replacement trials in children with DFNB9 demonstrated partial restoration of hearing, establishing the first clinical proof-of-concept for cochlear gene therapy. Preclinical studies confirm durable auditory and vestibular rescue using dual-AAV systems, while CRISPR-based editing, antisense oligonucleotides (ASOs), and RNA interference (RNAi) approaches show mechanistic feasibility. Induced pluripotent stem cells (iPSCs) and inner-ear organoids replicate key developmental pathways, supporting modeling and future cellular repair. Delivery precision via the round window, oval window, and microneedle systems remains the major translational bottleneck. Conclusions Gene- and cell-based approaches are transforming auditory regenerative medicine. Among them, AAV-mediated OTOF replacement has reached clinical validation, whereas CRISPR, ASO/RNAi, and iPSC-derived regeneration continue at advanced preclinical stages. Future success will depend on refining delivery, ensuring long-term safety, and harmonizing ethical and regulatory oversight.
- 1 November 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (12) , 6393-6404
Comparative evaluation of subtotal and total tonsillectomy in the management of chronic tonsillopharyngitis in adults
Objectives To compare postoperative outcomes of subtotal (intracapsular) and total (extracapsular) tonsillectomy in adults with chronic tonsillopharyngitis, with focus on pain, primary (< 24 h) and secondary (2nd to 14th postoperative day) hemorrhage, hospital stay, and recurrence, and to evaluate the influence of surgical technique (coblation vs. cold dissection). Design Retrospective descriptive-analytical study. Setting Department of Otolaryngology, Ketteler Hospital, Offenbach, Germany. Participants Ninety-seven adults (18–60 years) undergoing subtotal or total tonsillectomy between 2016 and 2021, stratified into four subgroups: subtotal–coblation, subtotal–cold dissection, total–coblation, and total–cold dissection. Main outcome measures Postoperative pain (VAS and WHO scale), primary and secondary hemorrhage, hospital stay, reoperation, and antibiotic use. Results Subtotal tonsillectomy was associated with significantly lower pain scores (P = 0.031) and shorter hospital stay (mean 1.24 ± 0.66 days) compared with total tonsillectomy (mean 4.25 ± 1.25 days, P < 0.001). Coblation also reduced pain compared with cold dissection (P = 0.044). Primary hemorrhage rates did not differ significantly between subtotal and total procedures (6.3% vs. 11.9%, P = 0.28) or between surgical techniques (P = 0.52). In contrast, secondary hemorrhage was more frequent after total tonsillectomy (10.0% vs. 0%, P = 0.004), highest in the total–coblation group (14.6%) and absent in subtotal–cold dissection cases (P = 0.010 for four-group comparison). Reoperation (7.2%) and postoperative antibiotic use showed no significant intergroup differences. Conclusions Subtotal tonsillectomy, particularly when performed with coblation, offers advantages of reduced pain, shorter hospitalization, and lower secondary bleeding risk compared with total tonsillectomy, while maintaining comparable safety regarding primary hemorrhage. These findings support subtotal tonsillectomy as a less invasive, patient-centered alternative in selected adults, although prospective multicenter studies are required to confirm long-term and recurrence outcomes.
- 1 November 2025
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (12) , 6393-6404
Comparative evaluation of subtotal and total tonsillectomy in the management of chronic tonsillopharyngitis in adults
Objectives To compare postoperative outcomes of subtotal (intracapsular) and total (extracapsular) tonsillectomy in adults with chronic tonsillopharyngitis, with focus on pain, primary (< 24 h) and secondary (2nd to 14th postoperative day) hemorrhage, hospital stay, and recurrence, and to evaluate the influence of surgical technique (coblation vs. cold dissection). Design Retrospective descriptive-analytical study. Setting Department of Otolaryngology, Ketteler Hospital, Offenbach, Germany. Participants Ninety-seven adults (18–60 years) undergoing subtotal or total tonsillectomy between 2016 and 2021, stratified into four subgroups: subtotal–coblation, subtotal–cold dissection, total–coblation, and total–cold dissection. Main outcome measures Postoperative pain (VAS and WHO scale), primary and secondary hemorrhage, hospital stay, reoperation, and antibiotic use. Results Subtotal tonsillectomy was associated with significantly lower pain scores (P = 0.031) and shorter hospital stay (mean 1.24 ± 0.66 days) compared with total tonsillectomy (mean 4.25 ± 1.25 days, P < 0.001). Coblation also reduced pain compared with cold dissection (P = 0.044). Primary hemorrhage rates did not differ significantly between subtotal and total procedures (6.3% vs. 11.9%, P = 0.28) or between surgical techniques (P = 0.52). In contrast, secondary hemorrhage was more frequent after total tonsillectomy (10.0% vs. 0%, P = 0.004), highest in the total–coblation group (14.6%) and absent in subtotal–cold dissection cases (P = 0.010 for four-group comparison). Reoperation (7.2%) and postoperative antibiotic use showed no significant intergroup differences. Conclusions Subtotal tonsillectomy, particularly when performed with coblation, offers advantages of reduced pain, shorter hospitalization, and lower secondary bleeding risk compared with total tonsillectomy, while maintaining comparable safety regarding primary hemorrhage. These findings support subtotal tonsillectomy as a less invasive, patient-centered alternative in selected adults, although prospective multicenter studies are required to confirm long-term and recurrence outcomes.
- 5 August 2022
- Published by Taylor & Francis in Applied Neuropsychology: Child
- Vol. 13 (1) , 1-7
Psychometric properties of the Behavior Rating Inventory of Executive Function, second edition (BRIEF2) self-report form in Iranian adolescents
This study investigated the psychometric properties of a Persian translation of the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF2) Self-Report form.Participants were 589 t...
- 5 August 2022
- Published by Taylor & Francis in Applied Neuropsychology: Child
- Vol. 13 (1) , 1-7
Psychometric properties of the Behavior Rating Inventory of Executive Function, second edition (BRIEF2) self-report form in Iranian adolescents
This study investigated the psychometric properties of a Persian translation of the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF2) Self-Report form.Participants were 589 t...
- Open Access
- 15 May 2022
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 16 (3) , 205-210
The Effect of Chitohem Bleeding Inhibitor Powder on Pain and Bleeding After Tonsillectomy by Suturing Method
Study Design and Objectives: This study aimed to investigate Triamcinolone ointment’s effect on pain and bleeding after tonsillectomy by suturing method. Methods: The present study was performed as a single-blind clinical trial on 200 patients who underwent a total tonsillectomy in the ENT department of Loghman Hakim Hospital in Tehran during 2016. Candidates for total tonsillectomy were randomized into 2 groups one by one. Participants were randomly divided into 2 groups. Both groups matched homologically. Patients in both groups (intervention and control) underwent cold dissection total tonsillectomy. In addition to suturing, in the intervention group, Triamcinolone ointment was used to control the local bleeding at the surgical site. In the control group, only sutures were used to control bleeding. The studied variables included: bleeding and pain 24 hours after surgery, Time to start oral feeding. Result: The frequency of bleeding cases in the first 24 hours are included: 4 patients (5.63%) in the intervention group and 6 patients (8.45%) in the control group ( P = 0.01). The average time to start eating for patients who were treated with topical triamcinolone ointment was significantly less than those who were not treated with this ointment. Only 2 patients (2.77%) in the intervention group took analgesics in the first 24 hours after surgery, while and 11 patients (15.3%) in the control group received analgesics in the same time period. Conclusion: In general, the results of this study showed that the use of Triamcinolone ointment in total tonsillectomy could reduce bleeding, analgesics usage, and the time of feeding onset.
- 15 May 2022
- Published by MDPI AG in Craniomaxillofacial Trauma & Reconstruction
- Vol. 16 (3) , 205-210
Open AccessThe Effect of Chitohem Bleeding Inhibitor Powder on Pain and Bleeding After Tonsillectomy by Suturing Method
Study Design and Objectives: This study aimed to investigate Triamcinolone ointment’s effect on pain and bleeding after tonsillectomy by suturing method. Methods: The present study was performed as a single-blind clinical trial on 200 patients who underwent a total tonsillectomy in the ENT department of Loghman Hakim Hospital in Tehran during 2016. Candidates for total tonsillectomy were randomized into 2 groups one by one. Participants were randomly divided into 2 groups. Both groups matched homologically. Patients in both groups (intervention and control) underwent cold dissection total tonsillectomy. In addition to suturing, in the intervention group, Triamcinolone ointment was used to control the local bleeding at the surgical site. In the control group, only sutures were used to control bleeding. The studied variables included: bleeding and pain 24 hours after surgery, Time to start oral feeding. Result: The frequency of bleeding cases in the first 24 hours are included: 4 patients (5.63%) in the intervention group and 6 patients (8.45%) in the control group ( P = 0.01). The average time to start eating for patients who were treated with topical triamcinolone ointment was significantly less than those who were not treated with this ointment. Only 2 patients (2.77%) in the intervention group took analgesics in the first 24 hours after surgery, while and 11 patients (15.3%) in the control group received analgesics in the same time period. Conclusion: In general, the results of this study showed that the use of Triamcinolone ointment in total tonsillectomy could reduce bleeding, analgesics usage, and the time of feeding onset.